Yixintang Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 6,701.565 million compared to CNY 6,028.944 million a year ago. Operating income was CNY 588.508 million compared to CNY 505.581 million a year ago. Net income was CNY 523.869 million compared to CNY 416.355 million a year ago. Basic earnings per share from continuing operations was CNY 0.8876 compared to CNY 0.7333 a year ago.